Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam T Gates

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Virus Research|March 17, 2004
Sequence requirements for the development of a chimeric HCV replicon systemAdam T Gates, Robert T Sarisky, Baohua Gu
Protein and Peptide Letters|May 24, 2005
The RNA-unwinding activity of hepatitis C virus non-structural protein 3 (NS3) is positively modulated by its protease domainBaohua Gu, Cynthia M Pruss, Adam T Gates, et al.
Journal of Virology|April 15, 2003
Replication studies using genotype 1a subgenomic hepatitis C virus repliconsBaohua Gu, Adam T Gates, Olaf Isken, et al.
Journal of Virology|March 13, 2009
A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expressionKara S Keedy, Nancie M Archin, Adam T Gates, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Resistance profile of a hepatitis C virus RNA-dependent RNA polymerase benzothiadiazine inhibitorTammy T Nguyen, Adam T Gates, Lester L Gutshall, et al.
Circulation Research|September 23, 2006
ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodelingRene Chapados, Khotaro Abe, Kaori Ihida-Stansbury, et al.
Cell Host & Microbe|November 4, 2008
Genome-scale RNAi screen for host factors required for HIV replicationHonglin Zhou, Min Xu, Qian Huang, et al.
Nucleic Acids Research|July 17, 2008
Hit selection with false discovery rate control in genome-scale RNAi screensXiaohua Douglas Zhang, Pei Fen Kuan, Marc Ferrer, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
The Journal of Biological Chemistry|August 9, 2002
Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymeraseDashyant Dhanak, Kevin J Duffy, Victor K Johnston, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Virus Research|March 17, 2004
Sequence requirements for the development of a chimeric HCV replicon systemAdam T Gates, Robert T Sarisky, Baohua Gu
Protein and Peptide Letters|May 24, 2005
The RNA-unwinding activity of hepatitis C virus non-structural protein 3 (NS3) is positively modulated by its protease domainBaohua Gu, Cynthia M Pruss, Adam T Gates, et al.
Journal of Virology|April 15, 2003
Replication studies using genotype 1a subgenomic hepatitis C virus repliconsBaohua Gu, Adam T Gates, Olaf Isken, et al.
Journal of Virology|March 13, 2009
A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expressionKara S Keedy, Nancie M Archin, Adam T Gates, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Resistance profile of a hepatitis C virus RNA-dependent RNA polymerase benzothiadiazine inhibitorTammy T Nguyen, Adam T Gates, Lester L Gutshall, et al.
Circulation Research|September 23, 2006
ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodelingRene Chapados, Khotaro Abe, Kaori Ihida-Stansbury, et al.
Cell Host & Microbe|November 4, 2008
Genome-scale RNAi screen for host factors required for HIV replicationHonglin Zhou, Min Xu, Qian Huang, et al.
Nucleic Acids Research|July 17, 2008
Hit selection with false discovery rate control in genome-scale RNAi screensXiaohua Douglas Zhang, Pei Fen Kuan, Marc Ferrer, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
The Journal of Biological Chemistry|August 9, 2002
Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymeraseDashyant Dhanak, Kevin J Duffy, Victor K Johnston, et al.
Pageof 2